A meta-analysis of treatment outcome for panic disorder

Clinical Psychology Review

Volumn 15, Issue 8, 1995, Pages 819-844

  Gould, Robert A ^a   Ott, Michael W ^a   Pollack, Mark H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; DIAZEPAM; IMIPRAMINE; PHENELZINE; PLACEBO; PROPRANOLOL; TRAZODONE;

BEHAVIOR THERAPY; DRUG EFFICACY; GROUP THERAPY; HUMAN; PANIC; PSYCHOPHARMACOTHERAPY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029568041     PISSN: 02727358     EISSN: None     Source Type: Journal    
DOI: 10.1016/0272-7358(95)00048-8     Document Type: Article

References (72)

1. Efficacy and safety of alprazolam imipramine and placebo in treating panic disorder A Scandinavian multicenter study
2. Enhancing agoraphobia treatment outcome by changing couple communication patterns
3. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial
4. Behavioral treatment of panic disorder
5. Cognitive approaches to panic disorder: Theory and therapy
6. A crossover study of focused cognitive therapy for panic disorder
7. A comparison of cognitive therapy and relaxation training for panic disorder
8. Mechanisms of change in the treatment of panic
9. Exposure and communication training in the treatment of agoraphobia
10. Cognitive therapy of anxiety disorders
11. Drug treatment of panic disorder: The comparative efficacy of imipramine, alprazolam, and trazodone
12. Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo controlled study
13. A cognitive approach to panic
14. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder
15. A meta-analysis for panic disorder
16. A comparison of guided imaginal coping and imaginal exposure in the treatment of panic disorder
17. Behavioral treatment of panic: A two year follow-up
18. Cross-national collaborative panic study
19. Long-term outcome of panic states during double-blind treatment and after withdrawal of alprazolam and placebo
20. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: A controlled study
21. A 1-year prospective study of panic attacks: Clinical course and factors associated with maintenance
22. Cognition and exposure in vivo in the treatment of agoraphobia: Short-term and delayed effects
23. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks
24. The use of bibliotherapy in the treatment of panic: A preliminary investigation
25. Self-help treatment for panic disorder: A replication and extension
26. Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder
27. Mechanisms of action of drugs used in the pharmacotherapy of panic disorder
28. Cognitive-behavioral treatment for panic disorder: A one-year follow-up study
29. Clomipramine treatment of agoraphobic women
30. Self-selection and sample selection in a treatment study of social phobia
31. Propanolol in chronic anxiety disorders
32. A comparison of alprazolam and behavior therapy in the treatment of panic disorder
33. Cognitive behavioral treatment of agoraphobia
34. Psychological treatment of panic: Work in progress on outcome, active ingredients, and follow-up
35. Alprazolam and exposure alone and combined in panic disorder with agoraphobia
36. Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework
37. Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobia
38. Cognitive-behavioral treatment of agoraphobia: Paradoxical intention vs. self-statement training
39. Agoraphobia: Relative and combined effectiveness of therapistassisted in vivo exposure and imipramine
40. Psychological approaches to panic disorder: A review
41. Cognitive, behavioral and psychophysiological treatments of agoraphobia: A comparitive outcome investigation
42. Alprazolam, propanolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks
43. Treatment of panic disorder (consensus statement)
44. Applied relaxation vs. progressive relaxation in the treatment of panic disorder
45. Statistical methods for clinical psychopharmacology trials
46. Treatment strategies for panic disorder: A debate
47. Cognitive-behavioral treatment of panic disorder Considerations for the treatment of patients over the long term
48. Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavior therapy for patients with panic disorder
49. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial
50. Long-term outcome after acute treatment with clonazepam and alprazolam for panic disorder
51. Cognitive behavior therapy for treatment-refractory panic disorder
52. Benzodiazepines in panic-related disorders
53. Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research
54. Maintenance drug treatment of panic disorder: Results of a prospective, placebo-controlled comparison of alprazolam and imipramine
55. Standardized assessment for panic disorder research: A conference report
56. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms
57. Does cognitive behavior therapy assist slowtaper alprazolam discontinuation in panic disorder?
58. Group cognitive-behavioral treatment of panic disorder
59. Group cognitive-behavioral treatment of panic disorder
60. Combined pharmacological and behavioral treatment of agoraphobia
61. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder
62. Behavioral and physiological effects of short-term and long-term administration of clonidine in panic disorder
63. Meta-analysis of double-blind placebo controlled trials of antidepressants and benzodiazepines for patients with panic disorders
64. Cognitive treatment in the natural environment for agoraphobics
65. Treatment of agoraphobia with group exposure in vivo and imipramine